Literature DB >> 26286930

Vascular Pythiosis of the Lower Extremity in Northern Thailand: Ten Years' Experience.

Termpong Reanpang1, Saritphat Orrapin1, Saranat Orrapin1, Supapong Arworn1, Thanate Kattipatanapong2, Tanop Srisuwan2, Nongnuch Vanittanakom3, Suree P Lekawanvijit4, Kittipan Rerkasem5.   

Abstract

Pythiosis is a disease caused by Pythium insidiosum, a fungus-like organism. P. insidiosum is pathogenic in mammals, particularly in horses, dogs, and humans. Human pythiosis can be classified into 4 types: (1) cutaneous/subcutaneous, (2) ocular, (3) vascular, and (4) disseminated pythiosis. Vascular pythiosis is a rare disease but a serious limb- and life-threatening infection. We reviewed 22 cases over a 10-year period in Maharaj Nakorn Chiang Mai/Chiang Mai University Hospital. The survival rate was around 63.6% during our follow-up period. The only effective treatment was complete excision of the infected tissue, which was done mainly by major amputation, such as above-knee amputation. This report raises awareness of this disease, which needs preemptive diagnosis and appropriate treatment.
© The Author(s) 2015.

Entities:  

Keywords:  Pythium insidiosum; aneurysm; gangrene; pythiosis

Mesh:

Year:  2015        PMID: 26286930     DOI: 10.1177/1534734615599652

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  8 in total

1.  In Vitro Activities of Miltefosine and Antibacterial Agents from the Macrolide, Oxazolidinone, and Pleuromutilin Classes against Pythium insidiosum and Pythium aphanidermatum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Daniele C Oliveira; Janio M Santurio; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β-d-Glucan in Vascular Pythiosis.

Authors:  Navaporn Worasilchai; Nitipong Permpalung; Pakawat Chongsathidkiet; Asada Leelahavanichkul; Alberto Leonel Mendoza; Tanapat Palaga; Rangsima Reantragoon; Malcolm Finkelman; Pranee Sutcharitchan; Ariya Chindamporn
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

3.  Efficacy of Azithromycin and Miltefosine in Experimental Systemic Pythiosis in Immunosuppressed Mice.

Authors:  Erico S Loreto; Juliana S M Tondolo; Francielli P K de Jesus; Camila M Verdi; Carla Weiblen; Maria I de Azevedo; Glaucia D Kommers; Janio M Santurio; Régis A Zanette; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 4.  Diagnosis and Treatment of Pythium Insidiosum Corneal Ulcer in a Chinese Child: A Case Report and Literature Review.

Authors:  Hong He; Hongshan Liu; Xiaolian Chen; Jiaochan Wu; Miao He; Xingwu Zhong
Journal:  Am J Case Rep       Date:  2016-12-27

5.  Pythium keratitis in South India: Incidence, clinical profile, management, and treatment recommendation.

Authors:  Ravula Hasika; Prajna Lalitha; Naveen Radhakrishnan; Gunasekaran Rameshkumar; N Venkatesh Prajna; Muthiah Srinivasan
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

Review 6.  Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum.

Authors:  Hanna Yolanda; Theerapong Krajaejun
Journal:  Heliyon       Date:  2020-04-12

7.  Clinical Outcomes of Radical Surgery and Antimicrobial Agents in Vascular Pythiosis: A Multicenter Prospective Study.

Authors:  Pattama Torvorapanit; Nipat Chuleerarux; Rongpong Plongla; Navaporn Worasilchai; Kasama Manothummetha; Achitpol Thongkam; Nattapong Langsiri; Jaruwan Diewsurin; Prasopchai Kongsakpaisan; Ratiporn Bansong; Nuttapon Susaengrat; Watchara Wattanasoontornsakul; Ariya Chindamporn; Nitipong Permpalung
Journal:  J Fungi (Basel)       Date:  2021-02-04

8.  Global Distribution and Clinical Features of Pythiosis in Humans and Animals.

Authors:  Hanna Yolanda; Theerapong Krajaejun
Journal:  J Fungi (Basel)       Date:  2022-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.